` KNB (Kanabo Group PLC) vs FTSE All Share Index Comparison - Alpha Spread

KNB
vs
F
FTSE All Share Index

Over the past 12 months, KNB has outperformed FTSE All Share Index, delivering a return of -84% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
KNB vs FTSE All Share Index

Loading
KNB
FTSE All Share Index
Add Stock
www.alphaspread.com

Performance Gap
KNB vs FTSE All Share Index

Loading
KNB
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
KNB vs FTSE All Share Index

Loading
KNB
FTSE All Share Index
Add Stock

Competitors Performance
Kanabo Group PLC vs Peers

FTSE All Share Index
KNB
LLY
JNJ
NOVO B
ROG
Add Stock

Kanabo Group PLC
Glance View

Market Cap
1.4m GBX
Industry
Pharmaceuticals

Kanabo Group Plc engages in the acquisition of a target company and business in the energy and industrial sectors. The firm is principally focused on distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for Cannabidiol (CBD) consumers. The company has developed a formula for sleep disorders (insomnia), three CBD formulations for Reload, Relax, and Repair, and the VapePod, which is a vaporization delivery system for cannabis extract. The firm's R&D lab is set up in the Weizmann Science Park. The firm's clinical and validation activities, including safety and efficiency tests, are conducted in Israel. The firm is selling its initial products in Europe. The company is also engaged in conducting research and development (R&D) to develop cannabis oil formulas, medical-grade vaporizers, and various non-smoking consumption solutions.

KNB Intrinsic Value
0.602 GBX
Undervaluation 63%
Intrinsic Value
Price
Back to Top